Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.540 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.540
Bid (Size) 5.240 (500)
Ask (Size) 6.000 (100)
Prev. Close 5.540
Today's Range 5.540 - 5.540
52wk Range 4.930 - 114.00
Shares Outstanding 620,290
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Preclinical Study Suggests Combo Therapy Could Treat Glioblastoma
Via Investor Brand Network
Experts’ Views on Screen Time and Lifestyle on Pediatric Brain Tumors
Via Investor Brand Network

Performance

YTD
+4.5%
+4.5%
1 Month
-23.2%
-23.2%
3 Month
-47.6%
-47.6%
6 Month
-50.9%
-50.9%
1 Year
-91.7%
-91.7%

More News

Read More
New Blood Test Reveals Whether Treatment is Working for Brain Cancer Patients
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces CEO Transition
Via ACCESS Newswire
Researchers Use Supplements to Produce Remarkable Outcomes in Brain Cancer Treatment
Via Investor Brand Network
Optimal Treatment Timing Could Boost Cancer Therapy Efficacy
Via Investor Brand Network
Nasal Drops Hold Promise in Fighting Deadly Brain Cancer
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast
Via Investor Brand Network
Common Drug for Blood Pressure Could Slow Glioblastoma
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Via ACCESS Newswire
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs
Via Investor Brand Network
Wegovy, Ozempic Could Reduce Deaths Resulting from Colon Cancer
Via Investor Brand Network
Topics Death
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
New Implants Defy Necessity of Brain Surgery Against Cancer
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
Via ACCESS Newswire
Review Shows That Neurocognitive Functioning Declines in Patients with CNS Cancers
Via Investor Brand Network
What Patients Need to Know About the Remission Rate of Glioblastomas
Via Investor Brand Network
Scientists Uncover Possible Driver of ‘Chemo Brain’
Via Investor Brand Network
Virtual Brain Tumors Could Transform How Cancer is Treated
Via Investor Brand Network
New AI Tool Boosts Precision Medicine in Treating CNS Cancers
Via Investor Brand Network
Topics Artificial Intelligence
Scientists Stunned Upon Discovering Glioblastoma Erodes Skull Tissue
Via Investor Brand Network
Scorpion Venom Shows Promise in Brain Tumor Treatment
Via Investor Brand Network
Rogue Rings of DNA Expose Brain Tumor Secrets
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 5.540
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.44M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.